A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

MLA

Moodley D, et al. “A Multicenter Randomized Controlled Trial of Nevirapine versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1.” Journal of Infectious Diseases, vol. 187, no. 5, Mar. 2003, pp. 725–35. EBSCOhost, https://doi.org/10.1086/367898.

APA

Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, & South African Intrapartum Nevirapine Trial Investigators. (2003). A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. Journal of Infectious Diseases, 187(5), 725–735. https://doi.org/10.1086/367898

Chicago

Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, et al. 2003. “A Multicenter Randomized Controlled Trial of Nevirapine versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1.” Journal of Infectious Diseases 187 (5): 725–35. doi:10.1086/367898.